Amicus Therapeutics Inc (FOLD) — Working Capital to Net Assets Ratio
Amicus Therapeutics Inc (FOLD) has a Working Capital to Net Assets ratio of 159.8% as of December 2025. Working capital of $438.35 Million (current assets of $676.17 Million minus current liabilities of $237.83 Million) is measured against net assets of $274.24 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See FOLD net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Amicus Therapeutics Inc Working Capital to Net Assets (2005–2025)
This chart shows how Amicus Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of December 2025, the ratio stands at 159.8%, reflecting working capital of $438.35 Million against net assets of $274.24 Million USD. Check Amicus Therapeutics Inc (FOLD) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Amicus Therapeutics Inc (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Amicus Therapeutics Inc from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Amicus Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 159.8% | $438.35 Million | $274.24 Million | $676.17 Million | $237.83 Million | ▼ -23.6 pp |
| 2024 | 183.5% | $356.03 Million | $194.04 Million | $504.74 Million | $148.70 Million | ▼ -13.4 pp |
| 2023 | 196.9% | $315.37 Million | $160.17 Million | $483.06 Million | $167.69 Million | ▼ -34.6 pp |
| 2022 | 231.5% | $284.80 Million | $123.05 Million | $423.82 Million | $139.02 Million | ▲ +84.8 pp |
| 2021 | 146.7% | $450.86 Million | $307.37 Million | $596.83 Million | $145.97 Million | ▼ -10.4 pp |
| 2020 | 157.1% | $449.79 Million | $286.38 Million | $579.47 Million | $129.68 Million | ▲ +74.9 pp |
| 2019 | 82.1% | $391.26 Million | $476.43 Million | $520.07 Million | $128.81 Million | ▼ -53.5 pp |
| 2018 | 135.6% | $464.97 Million | $342.91 Million | $551.10 Million | $86.12 Million | ▲ +44.4 pp |
| 2017 | 91.2% | $321.93 Million | $352.85 Million | $391.96 Million | $70.04 Million | ▲ +27.6 pp |
| 2016 | 63.6% | $229.10 Million | $360.15 Million | $340.06 Million | $110.96 Million | ▲ +22.5 pp |
| 2015 | 41.1% | $142.99 Million | $347.83 Million | $216.60 Million | $73.62 Million | ▼ -68.9 pp |
| 2014 | 110.0% | $134.39 Million | $122.18 Million | $154.58 Million | $20.18 Million | ▼ -60.1 pp |
| 2013 | 170.1% | $77.82 Million | $45.75 Million | $88.28 Million | $10.46 Million | ▲ +32.3 pp |
| 2012 | 137.8% | $95.37 Million | $69.22 Million | $104.62 Million | $9.24 Million | ▼ -22.4 pp |
| 2011 | 160.2% | $47.39 Million | $29.59 Million | $66.65 Million | $19.26 Million | ▲ +16.2 pp |
| 2010 | 143.9% | $93.46 Million | $64.93 Million | $109.68 Million | $16.22 Million | ▲ +47.5 pp |
| 2009 | 96.5% | $69.29 Million | $71.83 Million | $80.49 Million | $11.19 Million | ▼ -58.7 pp |
| 2008 | 155.1% | $110.21 Million | $71.04 Million | $123.59 Million | $13.38 Million | ▲ +12.6 pp |
| 2007 | 142.5% | $147.25 Million | $103.30 Million | $163.04 Million | $15.79 Million | ▲ +200.4 pp |
| 2006 | -57.8% | $44.81 Million | $-77.52 Million | $55.02 Million | $10.21 Million | ▲ +4.3 pp |
| 2005 | -62.1% | $22.27 Million | $-35.83 Million | $24.86 Million | $2.59 Million | — |